Drawing for CLINICAL COPILOT

USPTO serial 97871057

CLINICAL COPILOT

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
MARCY, AMY ALFIERI
Law office
TMEG LAW OFFICE 109

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with CLINICAL COPILOT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Tina Chen

Tina Chen BEYER LAW GROUP LLP2595 E. BAYSHORE ROADSUITE 100PALO ALTO, CA 94303

Goods and services

ClassDescriptionStatusFirst use
042Providing online non-downloadable real-time recommendation engine software based on artificial intelligence and algorithms for medical diagnosis and treatment; specifically excluding software for medical imaging and imaging software in field of radiation oncology, nuclear medicine, radiology, interventional radiology, theranostics, urology, molecular imaging, neuroimaging, and cardiac imaging; Providing online non-downloadable software using automated algorithms, artificial intelligence, and computational evidence to provide situational awareness and next-best-action suggestions for the understanding, diagnosis, treatment and prevention of medical conditions, all of the foregoing specifically excluding software for medical imaging and imaging software in fields of radiation oncology, nuclear medicine, radiology, interventional radiology, theranostics, urology, molecular imaging, neuroimaging, and cardiac imagingACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jun 30, 2025MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jun 30, 2025ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 18, 2025GNFNNOTIFICATION OF FINAL REFUSAL EMAILED
Feb 18, 2025GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 18, 2025CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 25, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Sep 25, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 25, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 25, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 25, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 25, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 16, 2024LOPELETTER OF PROTEST EVIDENCE REVIEWED - ACTION TAKEN
Dec 28, 2023DOCKASSIGNED TO EXAMINER
Oct 16, 2023TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Oct 16, 2023PARITEAS VOLUNTARY AMENDMENT RECEIVED
Oct 11, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 15, 2023LOPTLETTER OF PROTEST EVIDENCE FORWARDED
Apr 27, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 6, 2023NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance